Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat

NCT02802163 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study drug unavailable

Conditions

Multiple Myeloma

Interventions

DRUG: Panobinostat
DRUG: Carfilzomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]